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Glycosaminoglycans in the form of heparan sulfate proteoglycans (HSPG) and chondroitin sulfate proteoglycans (CSPG) are required for
normal kidney organogenesis. The specific roles of HSPGs and CSPGs on ureteric bud (UB) branching morphogenesis are unclear, and past
reports have obtained differing results. Here we employ in vitro systems, including isolated UB culture, to clarify the roles of HSPGs and CSPGs
on this process. Microarray analysis revealed that many proteoglycan core proteins change during kidney development (syndecan-1,2,4,
glypican-1,2,3, versican, decorin, biglycan). Moreover, syndecan-1, syndecan-4, glypican-3, and versican are differentially expressed during
isolated UB culture, while decorin is dynamically regulated in cultured isolated metanephric mesenchyme (MM). Biochemical analysis indicated
that while both heparan sulfate (HS) and chondroitin sulfate (CS) are present, CS accounts for approximately 75% of the glycosaminoglycans
(GAG) in the embryonic kidney. Selective perturbation of HS in whole kidney rudiments and in the isolated UB resulted in a significant reduction
in the number of UB branch tips, while CS perturbation has much less impressive effects on branching morphogenesis. Disruption of endogenous
HS sulfation with chlorate resulted in diminished FGF2 binding and proliferation, which markedly altered kidney area but did not have a
statistically significant effect on patterning of the ureteric tree. Furthermore, perturbation of GAGs did not have a detectable effect on FGFR2
expression or epithelial marker localization, suggesting the expression of these molecules is largely independent of HS function. Taken together,
the data suggests that nonselective perturbation of HSPG function results in a general proliferation defect; selective perturbation of specific core
proteins and/or GAG microstructure may result in branching pattern defects. Despite CS being the major GAG synthesized in the whole
developing kidney, it appears to play a lesser role in UB branching; however, CS is likely to be integral to other developmental processes during
nephrogenesis, possibly involving the MM. A model is presented of how, together with growth factors, heterogeneity of proteoglycan core
proteins and glycosaminoglycan sulfation act as a switching mechanism to regulate different stages of the branching process. In this model,
specific growth factor–HSPG combinations play key roles in the transitioning between stages and their maintenance.
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Branching morphogenesis is a central feature of the
developmental program of epithelial organs as diverse as
kidney, lung, breast, liver, and pancreas, and results from a
complex interaction between mesenchymal and epithelial
components. In the developing kidney, studies with the
isolated ureteric bud (UB) in culture suggest that the
branching program is induced by the activation of cell
surface receptors by soluble growth factors (Qiao et al.,
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such as matrix proteases (and their inhibitors) (Pohl et al.,
2000a). Proteoglycans (PG) have been identified as media-
tors of growth factor–receptor interactions and are also
major constituents of the extracellular milieu (Perrimon
and Bernfield, 2000); thus, they are likely to play key roles
in the development of these organs.
Proteoglycans consist of a protein core coupled to unique,
variably sulfated glycosaminoglycan (GAG) chains. Two
types of GAG chains predominate, heparan sulfate (HS), or
chondroitin sulfate (CS), and there appears to be a large
degree of structural diversity within these chains based on
variable sulfation and uronic acid composition. The HSPGs
include the syndecan and glypican gene families, and the
matrix proteoglycans perlecan, agrin, and collagen XVIII.
Glypicans and syndecans are attached to the cell surface;
syndecans are transmembrane proteins, while glypicans are
glycosylphosphoinositide-linked proteins. Perlecan, agrin,
and collagen XVIII proteoglycans are associated with base-
ment membranes. A wide variety of growth factors and
morphogens implicated in branching morphogenesis or other
aspects of kidney development, such as FGFs (Allen et al.,
2001; Clayton et al., 2001; Qiao et al., 2001), members of the
TGFh superfamily (Bush et al., 2004; Sakurai and Nigam,
1997; Santos and Nigam, 1993), GDNF (Barnett et al.,
2002), pleiotrophin (Sakurai et al., 2001), BMPs (Bush
et al., 2004; Grisaru et al., 2001), Wnts (Kispert et al.,
1996), and hedgehog (The et al., 1999), interact with HS
and often require this interaction for downstream signaling.
A role for HSPGs in development, and more specifically
kidney development, has been demonstrated in studies
involving genetically mutated mice. At several steps in the
biosynthesis of HSPGs, mutations have been found that
disrupt normal development (reviewed in Shah et al., 2004).
For example, mice lacking Heparan sulfate 2-sulfotransfer-
ase (Hs2st), a gene that encodes an enzyme responsible for
sulfating iduronic acid and glucuronic acid residues on HS,
die in the neonatal period due to renal agenesis (Bullock et
al., 1998; Merry et al., 2001). Mutations in the core proteins
themselves also can lead to renal defects. Glypican-3-
deficient mice exhibit developmental overgrowth, cystic
and dysplastic kidneys, and defective lung development
(Cano-Gauci et al., 1999). These features are similar to
the human Simpson–Golabi–Behmel syndrome, which is
caused by mutations in the Glypican-3 gene (Pilia et al.,
1996). The role of CSPGs in kidney development has not
been well characterized and an abnormal kidney phenotype
has not been reported in the CSPG knockout mice generated
thus far (reviewed in Ameye and Young, 2002).
The mammalian kidney or metanephros, arises through
the interaction between the epithelial UB and the metaneph-
ric mesenchyme (MM). Through a series of reciprocal
inductive events, the UB invades the mesenchyme and then
undergoes multiple iterations of a branching program that
leads to the development of an extensive urinary collecting
system (reviewed in Bush et al., 2003; Pohl et al., 2000b;Steer et al., 2004; Shah et al., 2004). The MM condenses at
the tips of UB branches and undergoes a mesenchymal-to-
epithelial transition, thereby forming the nephron tubules
associated with each collecting duct. Although many of the
factors that initiate and control UB branching morphogen-
esis and mesenchymal transformation have been elucidated,
the roles of sulfated proteoglycans in these disparate pro-
cesses have not been clearly defined. Until recently, methods
to study UB branching morphogenesis as a process distinct
from surrounding MM differentiation were unsuccessful.
However, it is now known that the UB can be isolated from
the MM and cultured within a Matrigel/collagen extracellu-
lar matrix. When exposed to soluble growth factors and
media conditioned by mesenchymal cells, the isolated UB
enacts an elaborate branching program that is thought to be
intrinsic to the UB (Qiao et al., 1999). This assay allows for
the examination of direct effectors of UB branching mor-
phogenesis independent from secondary mesenchymal influ-
ences (Bush et al., 2004; Qiao et al., 2001; Zent et al., 2001).
Several studies have indirectly suggested the importance
of sulfated GAGs to kidney branching morphogenesis
(Davies et al., 1995; Lash et al., 1983; Lelongt et al.,
1988; Platt et al., 1987, 1990); however, there are discrep-
ancies in the precise role of HS and CS in this process. The
discrepancies range from measurements of the GAG com-
position of the kidney to the effects of CS and HS on
branching morphogenesis and mesenchymal to epithelial
transformation. Compounding the confusion is the fact that
all these studies were done in whole kidney organ culture,
making it impossible to determine whether the effects on the
UB are direct or indirect (via MM signals).
In this paper, we attempt to clarify the functions of HS
and CS in UB branching morphogenesis using in vitro
culture of the isolated UB. Our results indicate that while
CS is the most abundant GAG within the developing kidney,
HS appears to play a more significant role in modulating UB
branching. We find that, in aggregate, sulfated GAGs
regulate proliferation more than the branching pattern of
the UB, likely through an HS-mediated effect. These find-
ings put previous work on the role of sulfated proteoglycans
in ureteric bud branching morphogenesis in perspective. We
present a model of how HS regulates various stages of UB
branching, from UB outgrowth to the cessation of UB
branching, by modulating a growth-factor-dependent switch
mechanism important in the transitioning from one stage of
the branching program to another.Materials and methods
Materials
Tissue culture media were obtained from Mediatech and
bovine fetal calf serum obtained from Biowhittaker (East
Rutherford, NJ). Transwell filters (0.4-Am pore size) were
obtained from Costar (Corning, NY). Growth factor reduced
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Dickinson (Franklin Lakes, NJ). FGF1 and GDNF were
obtained from R&D systems (Minneapolis, MN). FITC-
conjugated Dolichos bifloris lectin (DB) was obtained from
Vector Laboratories (Burlingame, CA). The primary anti-
bodies against occludin [mouse monoclonal, Immunofluo-
rescence (IF) 1:100] were from Zymed (San Francisco, CA);
MT1-MMP (mouse monoclonal, IF: 1:500) and BrdU
(mouse monoclonal, IF 1:100) was from Calbiochem (San
Diego, CA); FGF-R2 (rabbit polyclonal, IF 1:100) from
Santa Cruz (Santa Cruz, CA). Cy2, Cy3 antimouse, or
antirabbit (IF: 1:100) secondary antibodies were from Jack-
son Immunoresearch Laboratories (West Grove, PA) as was
Alexa-568 coupled phalloidin (IF: 1:100). Heparitinase
(Heparin Lyase III) and chondroitinase ABC were obtained
from Associates of Cape Cod (East Falmouth, MA). Decalin
xyloside and naphthalene xyloside were synthesized as
previously described (Lugemwa and Esko, 1991). Biotiny-
lated FGF2 (IF: 1:500) was prepared as described (Bai et al.,
2001). Plasticware was from Falcon (Lincoln Park, IL). All
other reagents and chemicals, unless otherwise indicated,
were from Sigma (St. Louis, MO).
DNA array analysis of proteoglycan expression patterns
RNA preparation and analysis of embryonic day13, e15,
e17, e19, newborn, and adult rat kidneys was performed and
data analyzed as previously described (Stuart et al., 2001).
RNA from isolated UB from 0, 1, 3, and 5 days of culture
and from metanephric mesenchyme induced by spinal cord
at 0, 2, 4, 6, 14, 24, 72, and 120 h of culture was isolated
using the Strataprep Total RNA Microprep kit (Stratagene,
La Jolla, CA) as previously described (Stuart et al., 2003).
Briefly, duplicate samples for each condition consisting of
approximately 100 ng of total RNA were then used for
reverse transcription (RT), second strand synthesis, and in
vitro transcription (IVT) of cRNA. cRNA from the first
round of IVT was recovered and used as a template in a
second round of RT/IVT incorporating biotinylated nucleo-
tides as per Affymetrix protocol, producing approximately
80 Ag of labeled cRNA. Labeled cRNA probe (15 Ag) was
hybridized to Affymetrix Rat Genome U34A GeneChip
(Affymetrix, Santa Clara, CA), washed, stained, and
scanned per standard Affymetrix protocol. Data were ana-
lyzed as previously described (Qiao et al., 2001; Stuart et
al., 2001), allowing assignment of statistical significance to
observations and filtering for genes with the greatest relative
changes in the context of their baseline expression. Double
IVT expression data was compared with expression of the
gene accession number of single IVT whole kidney mRNA
expression.
[35S] Sulfate labeling of glycosaminoglycans
Isolation of whole kidney rudiments was performed as
described below. Isolated kidneys were cultured (37jC, 5%CO2, 100% humidity) in DMEM media supplemented with
10% fetal calf serum and 100 ACi 35SO4/ml and allowed to
grow for 3–4 days. After exposure of the tissues to labeled
precursors, medium was removed and samples were washed
three times with PBS. Tissues were then processed as
previously described (Esko et al., 1987).
Generation of BSN conditioned media
The Cellmax artificial capillary cell culture system was
inoculated with BSN cells as previously described (Sakurai
et al., 1997). Conditioned media was harvested according to
the manufacturer’s instructions.
Culture of isolated embryonic kidneys
Embryonic kidneys were isolated from gestational day
13.5 Sprague–Dawley rat embryos and applied to the top of
Transwell filters placed within individual wells of a 12-well
tissue culture dish. The isolated kidneys were cultured
(37jC, 5% CO2, 100% humidity) in DMEM/F12 media
supplemented with 10% fetal calf serum and varying con-
centrations of sodium chlorate, heparitinase, chondroitinase
ABC, and xylosides as indicated in the text. Kidneys were
cultured for 3–4 days, then fixed in 4% paraformaldehyde
and stained with fluorescein-conjugated D. bifloris lectin
(1:100).
Isolation and culture of UB
UBs were separated from the MM of E13 rat kidneys as
previously described (Qiao et al., 1999). Briefly, embry-
onic kidneys were lightly digested with trypsin and the
UBs separated from the MM using fine-tipped needles.
The UBs were suspended within a matrix containing
growth factor-reduced Matrigel and Type I collagen
(50:50 v/v) supplemented with DMEM and buffered by
HEPES and NaHCO3 to a pH of approximately 7.2. UBs
were applied to the top of a Transwell filter and cultured in
BSN-CM supplemented with 10% FCS, 125 ng/ml GDNF,
and 375–500 ng/ml FGF1 and varying concentrations of
sodium chlorate, heparitinase, chondroitinase ABC, decalin
xyloside, and naphthalene xyloside as indicated in the text.
UBs were allowed to grow for 6–7 days, then fixed in 4%
paraformaldehyde and stained with fluorescein-conjugated
D. bifloris lectin.
Immunocytochemistry and confocal analysis
Isolated UB grown in three-dimensional extracellular
matrix gels or whole cultured kidneys were fixed in 4%
paraformaldehyde (EM Sciences, Fort Washington, PA) for
30 min at room temperature and then washed with PBS. UBs
were dissected from the Transwell insert and excess extra-
cellular matrix (ECM) gel was removed. The UBs were
equilibrated in quenching solution (20 mM glycine, 75 mM
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2+Mg2+) for
30 min to reduce background fluorescence from the
surrounding gel. Tissue samples were then incubated for
1 h at 4jC in blocking buffer [0.05% Triton X-100, 0.75%
Fish gelatin (Sigma) in PBS]. Primary antibodies were
diluted in blocking buffer and incubation was performed
for 48 h at 4jC on a rocking stage. For control staining,
primary antibody was omitted. After incubation, three
washes with Solution I (0.05% Triton X-100 in PBS) were
performed over 24 h at 4jC while rocking. Secondary
antibodies in blocking buffer were incubated for 48 h at
4jC while rocking. Three washes in Solution I over a
24-h period at 4jC were then performed to remove
unbound secondary antibody, and then the samples were
mounted onto slides using Fluoromount (Southern Biotech-
nology Associated Inc, Birmingham, AL). Whole cultured
kidneys were permeabilized in blocking buffer for 1 h at
room temperature after fixation. Staining was then per-
formed per the basic protocol as above. Fluorescence was
examined by scanning laser confocal microscopy (Zeiss
LSM-510). Images were processed with Photoshop soft-
ware (Adobe, San Jose, CA).
Bromodeoxyuridine proliferation assay
Cultured whole kidneys were incubated for 3 h in the
presence of 100 AM bromodeoxyuridine (BrdU) and cul-
tured UBs were incubated for 12 h with 100 AM BrdU at
37jC. BrdU is incorporated into DNA of proliferating cells
during the S-phase of the cell cycle. Extensive washes with
PBS removed unincorporated BrdU. Whole kidneys and
UBs were fixed in 4% paraformaldehyde for 30 min at room
temperature (RT) and washed with PBS. Permeabilization
with 0.075% Saponin for 30 min at RT followed by
treatment with 1 N HCl for 30 min at RT were performed.
Tissues were rinsed in PBS and the basic staining protocol
was performed as described above. Samples were evaluated
by scanning laser confocal microscopy.
TUNEL apoptosis assay
TUNEL labeling of DNA strand breaks was performed in
whole kidneys and isolated UBs. Kidneys and isolated UBs
were fixed in 1% paraformaldehyde for 30 min at RT and
rinsed in PBS. The ECM gel was removed from around the
isolated UBs. TUNEL staining was then performed accord-
ing to the manufacturer’s instructions (Intergen, Purchase,
NY). Counterstaining with DB preceded mounting in Fluo-
romount. Samples were evaluated by scanning laser confo-
cal microscopy.
Morphometric quantification
Whole embryonic kidneys were grown as described in
the presence of sodium chlorate, heparitinase, chondroiti-
nase ABC, and xylosides. Tissues were photographed atdays 1, 3, and 5 then labeled with FITC-conjugated DB.
Images were obtained with confocal microscopy. Geometric
measurement of the DB-stained collecting system was
obtained from at least four structures per day of interest
using Image Pro Plus. These measurements include branch
angle, stalk length and thickness, and total area. Angles are
measured at branching points; stalk length is defined as the
distance between branch points. Stick figures were generat-
ed as a composite of the average of these measurements. To
account for differences in growth rate between control and
treated kidneys, treated kidney stalk lengths were scaled to
controls by normalizing with the ratio of the summed
averages of control kidney stalk lengths to treated kidney
stalk lengths.
Statistics
Each assay was performed in at least triplicate and data
are presented as mean values F SE The Student’s t test
was used to compare mean values between each experi-
mental group. The ANOVA single factor test was applied
to data from the morphometric quantification experiments.
A P value of <0.05 was accepted to indicate statistical
significance.Results
Proteoglycans are differentially expressed during kidney
development
We have previously analyzed the expression patterns of
8740 rat genes during whole kidney development and
demonstrated global changes in gene expression (Stuart et
al., 2001, 2003). This expression database was mined for
specific PGs of interest to identify expression patterns. We
first identified which PG sequences were represented on the
Affymetrix rat U34A GeneChip by blasting known PG
mRNA sequences against the oligonucleotide sequences
synthesized on the GeneChip. Using techniques previously
developed (Stuart et al., 2001, 2003), we then normalized
expression data and represented expression as a function of
maximal expression for each sequence. Additional informa-
tion regarding the approach to data normalization is avail-
able at http://www.organogenesis.ucsd.edu.
Table 1 highlights PG core protein sequences (present on
the U34A chip) that initially display the highest levels of
relative expression during early rat kidney development and
that then taper off during later fetal, neonatal, and adult
periods. In whole kidney, this group included syndecan-1,
glypican-1, glypican-2, and glypican-3 (all HSPGs), and
versican (a CSPG). The highest levels of expression were
during embryonic days 13 through 15, which correlate with
initial UB branching and mesenchymal induction events. As
discussed below, several of these PGs are particularly
interesting in the context of renal development.
Table 1
Proteoglycans expressed during rat kidney development in vivo
Proteoglycan Mutant phenotype Fold difference
(e13 to adulta)
Falling transcript expression during kidney development
Syndecan-1 Enhanced leukocyte adhesion to




(Alexander et al., 2000)
Enhanced feeding behavior
(Reizes et al., 2001)
Glypican-1 Unknown 5.3
Glypican-2 Unknown 9.6
Glypican-3 Nephromegaly, medullary dyplasia,
hydroureter (Cano-Gauci et al., 1999)
16.1
Versican Transgenic expression results in failure of
endocardial cushion cell migration
(Mjaatvedt et al., 1998)
16.9
Rising transcript expression during kidney development
Agrin Defective intramuscular nerve
branching and presynaptic differentiation
(Gautam et al., 1996)
1.5
Syndecan-2 Not reported 2.9
Syndecan-4 Mild defects in angiogenesis
(Echtermeyer et al., 2001) and focal
adhesion formation (Ishiguro et al., 2000)
7.2
Increased susceptibility to renal damage
(Ishiguro et al., 2001)
Biglycan Reduced growth rate and decreased
bone mass (Xu et al., 1998)
2.3
Decorin Fragile skin (Danielson et al., 1997) 8.5
Proteoglycan core proteins listed are those that display developmentally
regulated expression only in whole embryonic kidney. Core protein genes
that were not represented on the gene chip include glypican-4, 5, and 6,
syndecan-3 and collagen XVII.
a Gene expression analyzed in embryonic day13, e15, e17, e19, newborn,
and adult rat kidneys (Stuart et al., 2001).
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highest levels of relative expression during late embryonic
whole kidney development and in the neonate and adult.
This group includes the HSPGs syndecan-2 and syndecan-4
and the CSPGs biglycan and decorin. Syndecan-4 knockout
mice are found to have increased susceptibility to n-carra-
geenan-induced obstructive nephropathy compared to wild
type (Ishiguro et al., 2001); however, the roles for this group
of PGs during renal development are unclear.
There were additional proteoglycan genes that did not
display a developmentally regulated expression pattern. Our
survey found that there was no significant change in expres-
sion of perlecan in the embryonic kidney. Perlecan knockout
mice die at E10–12 due to ruptured basement membranes in
the heart, although there are no renal abnormalities in the
embryos that survive (Arikawa-Hirasawa et al., 1999; Cost-
ell et al., 1999). This analysis is limited by the representation
of PGs on the GeneChip. For example, the uronic acid
sulfotransferase, Hs2st, was not present on the gene chip
we used, although there does appear to be a critical role for
Hs2st in renal development (Bullock et al., 1998).Using the whole kidney developmental data as a filter,
we further investigated PG mRNA expression patterns in
UB, MM, cultured isolated ureteric bud, and spinal-cord-
induced metanephric mesenchyme and compared it to that
of the whole embryonic kidney. This allowed us to deter-
mine if developmental regulation of these PGs was limited
to the isolated UB or MM morphogenesis. It should be
noted, however, that each tissue represents a separate
experiment so that the absolute level between MM, UB,
and WEK are not directly comparable. Our data indicate that
there are marked changes in syndecan-4 and syndecan-1
expression in the epithelial ureteric bud during branching
morphogenesis (Figs. 1A,B). Expression of these genes in
the mesenchyme also appears to be regulated during nephro-
genesis. Immunocytochemical studies have previously
shown that syndecan-1 is transiently expressed in the
metanephric mesenchyme and then assembles into the
epithelium of the arborizing ureteric bud (Vainio et al.,
1992). Versican, a CSPG that has been found to be essential
in cardiac development, is also developmentally regulated in
the isolated UB and MM (Fig. 1C). Expression of glypican-
3 appears to be regulated in the isolated UB but not as
significantly in the MM (Fig. 1D). On the other hand, the
CSPG decorin is highly regulated in MM but not in the
isolated UB (Fig. 1E). This in vitro expression data hints at
more dynamic HSPG changes in the developing UB and
more dynamic CSPG changes in the developing MM.
This approach has several limitations. Isolated culture of
the UB may induce mRNA expression differently as com-
pared to whole kidney culture when the UB is in intimate
contact with mesenchyme; also, induction of MM with
spinal cord may not be directly comparable to induction
by the UB as spinal cord is a very potent inducer of
mesenchymal differentiation, and it may be contributing
an unknown factor for PG expression. However, the ex-
pression of both HSPG and CSPG core proteins are clearly
regulated during kidney organogenesis, and the expression
patterns detailed above are consistent with the concept that
there may be some PGs primarily involved in ureteric bud
branching while others may be specifically involved in
mesenchymal induction.
Chondroitin sulfates are the predominant GAG synthesized
by the developing kidney
The synthesis of HS and CS chains are also develop-
mentally controlled. Studies performed over the last 20
years, however, have reported conflicting results regarding
the relative contributions of CS and HS synthesis in the
developing kidney (Lelongt et al., 1988; Platt et al., 1987).
Our data support the finding that CS is the predominant
sulfated glycosaminoglycan synthesized by the fetal kid-
ney. By adding radioactive sulfate to the media of ex vivo
cultured embryonic day 13 rat kidneys, all newly made
GAGs were radiolabeled. After culture for 3 days, we then
isolated the total GAGs from these kidneys and quantitated
Fig. 1. Gene expression patterns in metanephric mesenchyme (MM) and isolated ureteric bud (iUB) and whole embryonic kidney (WEK). MM induced with
spinal cord was cultured up to 5 days. Isolated UBs were cultured up to 5 days. WEK were isolated from embryos at various developmental stages as indicated.
Using high-density DNA arrays, together with double in vitro transcription, gene expression patterns of specific proteoglycans (PG) of interest were analyzed in
WEK, MM, and iUB as previously described (Qiao et al., 2001; Stuart et al., 2001, 2003), allowing assignment of statistical significance to observations and
filtering of genes with the greatest relative changes in the context of their baseline expression. Graphs display representative time points for MM, iUB, and
WEK PG gene expression normalized to maximal expression in each tissue, thus the levels of expression between MM, iUB, and WEK are not directly
comparable. In some cases, the point with maximal expression is not shown. Syndecan-4 (A), syndecan-1 (B), and versican (C) are developmentally regulated
during kidney organogenesis in both UB and MM. Glypican-3 (D) is regulated during UB branching but not nephrogenesis. Decorin (E) is highly regulated
during nephrogenesis. WEK—whole embryonic kidney; nb—newborn; wk—1 week.
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digesting the isolated GAGs with chondroitinase ABC, we
were then able to determine the ratio of HS and CS that
comprised the total GAG concentration. We established
that CS comprise approximately 77% of the total GAG
population (and HS 23%) in the early embryonic rat kidney
(Fig. 2). This result is similar to that reported in induced
murine metanephric mesenchyme (Lash et al., 1983); thus,
our findings may reflect that the majority of GAG synthesis
occurring in the embryonic kidney arises from mesen-
chyme undergoing epithelial transformation and the contri-
bution of UB GAG synthesis may be comparatively minor.
Perturbation of HS in embryonic kidney culture inhibits UB
branching morphogenesis
Given the expression patterns of HSPGs and CSPGs and
the predominance of CS synthesis, we sought to determine
the specific roles that either CSPGs or HSPGs may play
during early metanephric development by perturbing their
function in whole rat embryonic kidney and in the isolated
ureteric bud. Normal sulfation patterns were disrupted byadding exogenous sodium chlorate to the culture medium.
Chlorate competitively blocks the formation of phophoade-
nosine 5V-phosphosulfate, the sulfate donor utilized by the
sulfotransferase enzymes that mediate polysaccharide sulfa-
tion, thus inhibiting sulfation of the newly made GAG
chains (Greve et al., 1988; Humphries and Silbert, 1988).
Existing PGs were also stripped of their GAG chains by the
addition of either heparitinase or chondroitinase ABC to the
culture medium. Finally, GAG synthesis on PG core pro-
teins was diminished by the addition of exogenous xylo-
sides, which act as a metabolic decoy for GAG synthesis
(Schwartz et al., 1974). Naphthalene xyloside blocks the
attachment of both HS and CS chains, whereas decalin
xyloside only affects CS attachment (Fritz et al., 1994). It is
worth noting that the action of perturbation by each of these
compounds is different. In the case of chlorate, the sulfation
of the GAG chain is inhibited, but the chain itself remains
intact. With the glycolytic enzymes, heparitinase and chon-
droitinase ABC, the chains are degraded into biologically
fragments. Xylosides, on the other hand, generate free
chains within the media and block the addition of the chains
to the proteoglycans; the free chains may have biological
Fig. 2. Glycosaminoglycan (GAG) synthesis in cultured embryonic kidney.
Newly synthesized 35S-labeled GAGs were isolated from cultured
embryonic day 13 rat kidneys. Elution of heparan sulfate (HS) and
chondroitin sulfate (CS) was performed via HPLC. HS elutes earlier than
CS. Before digestion with chondroitinase ABC (open circles), CS peak
encompasses 77% of total labeled GAG isolated, and HS 23%. Digestion
with chondroitinase ABC results in loss of the peak (closed circles),
confirming the presence of CS.
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that the primary effect is generally felt to be due to the
inhibition of GAG chain addition to core proteins.
Fig. 3 demonstrates functional GAG perturbation in rat
embryonic kidney culture. Previous studies have used chlo-
rate, heparitinase, and chondroitinase ABC to show that, in ex
vivo mouse whole kidney culture, altering GAGs inhibited
ureteric bud growth and branching but did not affect nephron
development (Davies et al., 1995). The set of experiments
shown in Fig. 3 extends this finding. Figs. 3A–J demonstrate
immunofluorescence of representative images of rat whole
embryonic kidneys subjected to various GAG perturbations
that have been stained with FITC-labeled D. bifloris (DB)
lectin, which specifically binds a carbohydrate antigen found
on UB epithelia (Laitinen et al., 1987). Fig. 3K quantitates
these findings and shows the number of ureteric bud tips per
kidney, which can be considered a direct measurement of the
extent of branching morphogenesis (Bush et al., 2004). UB
branching was found to be inhibited in a dose dependent
manner by chlorate (Figs. 3B–D). When chlorate treated
kidneys were cultured with an excess of sulfate, which
reverses the effect of chlorate, there was partial recovery of
branching (Fig. 3E); more complete recovery of branching
may have been inhibited due to the higher osmolarity of the
media (due to excess sulfate). Treatment of whole embryonic
kidney with heparitinase (Fig. 3F), but not chondroitinase
(Fig. 3G), also markedly impairs branching of the UB.
Inactivation of these enzymes by boiling resulted in restora-tion of branching to near normal levels (Fig. 3H). Finally,
perturbation solely of CS synthesis using decalin xyloside
only slightly affected branching of the UB (Fig. 3J) whereas
perturbation of both CS and HS by using naphthalene xylo-
side significantly affected branching (Fig. 3I).
Unfortunately, there is no available xyloside that inhibits
HS synthesis alone, but these data suggest that HS plays a
substantially greater role in UB branching morphogenesis
relative to CS. We also noted that heparitinase treated
kidneys had nearly absent in vitro nephron formation (Fig.
3N), although this may due to an effect of impaired
induction by the abnormally branched UB. On the other
hand, treatment with chlorate or chondroitinase ABC did
not appear to impair nephrogenesis (Figs. 3M,O). These
findings stand in contrast to the aforementioned study
(Davies et al., 1995), which suggests that perturbation of
both HS and CS have roughly comparable effects on
morphogenesis and growth of the ureteric bud in whole
kidney culture; however, in the previous studies, the authors
may not have been able to determine specific effects on the
UB owing to the lack of a suitable assay, which has recently
been developed (Qiao et al., 1999) (see below).
Perturbation of HS in isolated UB culture inhibits normal
branching morphogenesis
While these results confirm that HSPGs are important
mediators of branching morphogenesis in the whole embry-
onic rat kidney, they do not allow independent examination
of ureteric development isolated from local mesenchymal
factors. That is, when utilizing the whole kidney culture
model of renal development, ‘‘primary’’ effects on the
ureteric bud cannot be separated from effects mediated by
the local mesenchyme. This is a limitation of prior studies
(Davies et al., 1995; Lelongt et al., 1988; Platt et al., 1990).
Selective perturbation experiments were therefore carried out
on isolated ureteric bud culture where UBs isolated from
embryonic day 13 kidney rudiments are suspended within a
three-dimensional extracellular matrix and cultured in a
metanephric mesenchyme cell line conditioned media sup-
plemented with GDNF and FGF1 (Qiao et al., 1999, 2001).
Fig. 4 shows the addition of chlorate to the isolated ureteric
bud culture. Both overall size and extent of branching are
affected by perturbation of sulfation (Figs. 4B,D). The dose
dependent effect (Fig. 4A) was rescued by addition of sulfate
(Fig. 4D). Fig. 5 demonstrates representative images of
isolated UBs treated with chondroitinase ABC (Figs. 5B,C)
and heparitinase (Figs. 5D–F). These studies confirm that
the decrease in branching and size of the bud is a dose-
dependent function of perturbation of HS (Fig. 5H) but not
CS activity (Fig. 5G). Finally, naphthalene xyloside and
decalin xyloside were added to isolated UB culture. Naph-
thalene xyloside, which perturbs both HS and CS attach-
ment to PG core proteins, decreased UB branching by
approximately 50% (Figs. 6A–D,I). Decalin xyloside,
which interferes only with CS attachment, decreased UB
Fig. 3. Effects of perturbation of heparan sulfate (HS) and chondroitin sulfate (CS) in cultured embryonic kidney. (A–J) Embryonic day 13 rat kidneys were
isolated and cultured in vitro for 3 days, then labeled with FITC-conjugated D. bifloris lectin. Kidneys were grown in the absence (A, control) or presence of
varying concentrations of sodium chlorate (B–D), sodium chlorate (30 mM) plus sulfate (30 mM) (E), heparitinase (F, 100 mU/ml), chondroitinase ABC (G,
100 mU/ml), boiled heparitinase, and chondroitinase ABC (H), naphthalene xyloside that inhibits native synthesis of both HS and CS (I, 250 AM), or decalin
xyloside that inhibits native synthesis of CS alone (J, 250 AM). Far right panel (K): Graphical analysis of the average number of tips per kidney as a percentage
of control in whole kidney cultured with 30 mM chlorate (D), chlorate plus sulfate (E), boiled heparitinase and chondroitinase ABC (H), chondroitinase ABC
(G), heparitinase (F), naphthalene xyloside (I), or decalin xyloside (J). MeanF SEM, n z 3, *P V 0.05 (compared to control). (L–O) Phase-contrast images of
whole embryonic kidneys cultured in vitro for 4–5 days in the absence (L, control) or presence of 20 mM sodium chlorate (M), 100 mU/ml heparitinase (N), or
100 mU/ml chondroitinase ABC (O). Arrowheads indicate areas of mesenchymal to epithelial transformation (nephrogenesis); note the absence of the
characteristic swirls of mesenchymal to epithelial transformation in heparitinase-treated kidneys.
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statistically significant (Figs. 6E–H,J). These results indicate
that perturbation of endogenous HS function significantly
interferes with primary ureteric bud branching, both in
whole embryonic kidney culture and in isolated ureteric
bud culture. The role of CS in UB branching appears to be
considerably less than HS. It is possible that CS is involved
in branching morphogenesis on a more subtle level com-
pared to HS; however, the methods of quantitation used in
this study likely lack the sensitivity to detect such effects.
To further support the idea that the morphological
changes of the UB seen with GAG perturbation is actually
due to diminished HS function, we evaluated the binding of
FGF2 to whole kidneys and isolated UBs treated with
chlorate. A well-defined function of HS is to facilitate
binding of growth factors to their high-affinity receptors
(Krufka et al., 1996). This interaction is often determined by
the sulfation pattern of the HS molecule and has been best
characterized in several cell culture models of FGF2-medi-
ated receptor activation (Nakato and Kimata, 2002); thus,assessment of FGF2 binding is an indirect means of eval-
uating HS sulfation. Under control conditions (Figs. 7A,B),
FGF2 is found to be bound throughout the developing
nephrons (on both the ureteric bud and mesenchyme derived
segments). In the presence of chlorate, FGF2 binding is
markedly diminished (Figs. 7C,D). Diminution in FGF2
binding also occurred in isolated UBs cultured with chlo-
rate. Figs. 7E and F show the isolated UB grown under
control conditions and Figs. 7G and H in the presence of
chlorate. Note that FGF2 binding is wholly confined to the
basement membrane. There also appears to be a predomi-
nance of binding in the stalk regions vs. the ampullae of
chlorate treated isolated UBs, which may represent differ-
ential binding of FGF2 along the arborizing UB.
Perturbation of HSPGs and CSPGs does not significantly
change branch angles and stalk lengths of the UB
The inhibitory effects of nonselective HS perturbation on
UB branching morphogenesis could either be a result of a
Fig. 4. Effects of chlorate on branching of isolated ureteric bud (iUB).
Graphical analysis of the average number of tips (compared to control) per
isolated rat UB cultured in vitro for 6–7 days with varying concentrations
of sodium chlorate (1, 10, 20, and 30 mM) and sodium chlorate 20 mM +
sulfate 20 mM (A). Mean F SEM, n z 3, *P V 0.05 (compared to control).
Bottom panel (B–D) displays representative phase-contrast photomicro-
graphs of iUBs cultured in the absence (B, control) or presence of 20 mM
chlorate (C), and chlorate (20 mM) plus sulfate (20 mM) (D).
Fig. 5. Effects of chondroitinase ABC (CSase) and heparitinase (HSase) on bran
photomicrographs of iUBs cultured in the absence (A, control) or presence of chon
(D), 100 mU/ml (E), 500 mU/ml (F). Far right top panel, (G): graphical analysi
cultured with chondroitinase ABC 100 mU/ml (B) and 500 mU/ml (C). Far right b
to control) per isolated rat UB cultured with heparitinase 10 mU/ml (D), 100 mU
to control).
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fewer branching events or reorganization of the spatial
branching arrangement). We therefore quantified the reduc-
tion in the number of branch tips in kidneys exposed to
chlorate, heparitinase, or chondroitinase ABC by evaluating
whole kidney area and branch angles and stalk lengths at
each iteration of branching in control and in GAG-perturbed
kidneys. This analysis allows for relatively independent
evaluation of growth (based on tip number and area) and
branching pattern (based on relative stalk length and branch
angle) (Bush et al., 2004). Under control conditions, branch-
ing occurs in a uniform manner with fairly consistent stalk
lengths and branch angles. The result is a highly ordered,
arborized structure that maximizes area and minimizes
internal contacts. Fig. 8A shows the average area of control,
chlorate-, chondroitinase-, and heparitinase-treated kidneys.
Chlorate at higher concentrations (20 and 30 mM) and
heparitinase cause a significant reduction in the area of the
kidney, while lower concentrations of chlorate (10 mM) and
chondroitinase ABC treatment are similar to control. In
contrast, the average branch angle and stalk length did not
differ significantly between control and GAG perturbed
kidneys at the first branching iteration (Fig. 8B). The second
branching iteration also does not display significant differ-
ences between control and treated kidneys although hepar-
itinase-treated kidneys tend to have greater variations in
branch length compared to the other conditions (Fig. 8C).
Fig. 8D shows computer-generated composite models ofching of isolated ureteric bud (UB). (A–F) Representative phase-contrast
droitinase ABC 100 mU/ml (B), 500 mU/ml (C), or heparitinase 10 mU/ml
s of the average number of tips (compared to control) per isolated rat UB
ottom panel (H): graphical analysis of the average number of tips (compared
/ml (E), and 500 mU/ml (F). Mean F SEM, n z 3, *P V 0.05 (compared
Fig. 6. Effects of naphthalene xyloside and decalin xyloside on branching of isolated ureteric bud (UB). (A–H) Representative phase-contrast
photomicrographs of iUBs cultured in the absence (A, control) or presence of naphthalene xyloside 10 AM (B), 50 AM (C), 100 AM (D); or decalin xyloside 10
AM (F), 50 AM (G), 100 AM (H). Far right top panel, (I): graphical analysis of the average number of tips (compared to control) per isolated rat UB cultured
with naphthalene xyloside 10 AM (B), 50 AM (C), 100 AM (D). Far right bottom panel (H): graphical analysis of the average number of tips (compared to
control) per isolated rat UB cultured with decalin xyloside 10 AM (F), 50 AM (G), 100 AM (H). Mean F SEM, n z 3, *P V 0.05 (compared to control).
D.L. Steer et al. / Developmental Biology 272 (2004) 310–327 319chlorate- and heparitinase-treated embryonic kidneys com-
pared to control. These models were scaled to account for
differences in growth rate as distinct from branching events.
The superimposed figures demonstrate that chlorate-treated
kidneys have essentially the same branching pattern as
controls. On the other hand, despite similar branch lengths
and angles (i.e., patterning), heparitinase-treated kidneys are
stunted and appear markedly different from control. A
similar phenotype is seen in kidneys treated with 30 mM
chlorate (not shown). These results suggest that nonselective
perturbation of HS disrupts normal ‘‘growth’’ signals within
the developing UB and that CS perturbation does not affectFig. 7. FGF2 localization in cultured embryonic rat kidney and isolated rat ure
demonstrated with immunofluorescent labeling of biotin-conjugated FGF2 (red
embryonic day 13 kidney cultured in the absence (A,B control) or presence of chlo
while DB stains only UB. Bottom row (E–H) displays FGF2 staining of cultured isthese instructive signals. In these experiments, all types of
heparan sulfation are presumed to be perturbed; selective
perturbations (e.g., in O-sulfation or N-sulfation), which
may affect signaling of a specific growth factor, may reveal
patterning defects.
Proliferation is decreased in embryonic kidneys and
isolated UBs with altered GAG sulfation
Given the above results, we further investigated the
mechanism for the growth retardation observed after GAG
perturbation by evaluating proliferation and apoptosis interic bud (UB). Diminished FGF2 binding in chlorate-treated kidneys is
) and D. bifloris (DB) (green). Immunocytochemistry was performed in
rate 10 mM (C,D). FGF2 is found on both UB and mesenchymal structures
olated UB in the absence (E,F control) or presence of chlorate 30 mM (G,H).
Fig. 8. Area, branch angles, and stalk lengths in embryonic rat kidney. Graphs depict average area (A), average branch angle, and length at the first iteration of
branching (B), and the average branch angle and length at the second iteration of branching (C) in embryonic kidneys grown in the absence and presence of
various glycosaminoglycan perturbations. Figure legend in panel A represents all panels. Mean F SEM, n z 3, *P V 0.05 (compared to control). (D)
Composite models of branching in embryonic rat kidney. Stick figures represent average branch angle and stalk length at each iteration of branching,
normalized for differences in growth rate, in kidneys grown in the presence of chlorate 20 mM or heparitinase 5 mU/ml compared to control. Tip number is not
represented in this analysis.
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little is known about the balance of proliferation and
apoptosis in creating branch tips and stalks. Prior studies
in murine kidney rudiments have shown that the highest
rates of proliferation occur in uninduced mesenchyme, the
early stages of epithelial differentiation, and the tips of the
collecting ducts (Mugrauer and Ekblom, 1991), while
apoptosis appears to be most prominent in uninduced
mesenchyme (Koseki et al., 1992). Additionally, we have
recently extended these findings to show that in the
isolated ureteric bud, proliferation is almost wholly con-
fined to the distal tips of the branches (ampullae) while
apoptosis occurs at a higher rate in the branch stalks
(Meyer et al., submitted for publication). Disruption in
the balance of proliferation and apoptosis therefore likely
alters growth and possibly normal arborization patterns.
This is seen in cystic kidney disease where proliferation
and apoptosis are both diffusely increased and lead toaltered morphology and function of the tubules (Grisaru
et al., 2001).
Proliferation was evaluated by in vitro BrdU incorpora-
tion and subsequent immunocytochemistry for BrdU. Sim-
ilar to the aforementioned study, proliferating cells were
found primarily in the ampullae of control kidneys (Fig. 9A).
Chlorate-treated kidneys had a markedly diminished rate of
proliferation although the localization remained the same
(Fig. 9B). The same distribution of proliferation is found in
the isolated UB (Figs. 9C,D). This result suggests that there
is a putative molecule that stimulates ampullary growth that
is bound by HS or CS and its binding or function (or both) is
dependent on proper sulfation of the GAG. Figs. 9E and F
show apoptosis detected by TUNEL staining of 3V DNA
fragmentation in control and chlorate-treated isolated UBs.
Apoptotic cells were primarily found in the stalks in both
isolated UBs grown under control conditions (Fig. 9E) and
those in the presence of chlorate (Fig. 9F).
Fig. 9. Proliferation and apoptosis in cultured rat embryonic kidney and
isolated ureteric bud (UB). (A,B) Confocal microscopic immunofluorescent
localization of BrdU (green) in day 13 embryonic kidneys cultured in the
absence (A, control) or presence of chlorate 30 mM (B) for 3 days (D.
bifloris staining in red). As described in controls, proliferation appears to be
localized to the UB ampullae (A, arrowheads) and adjacent mesenchyme.
(C,D) Localization of BrdU (red) in isolated UB cultured without (C,
control) and with chlorate 30 mM (D) for 7 days (D. bifloris staining in
green). TUNEL staining (green) was performed on isolated UBs in the
absence (E, control) or presence of chlorate 30 mM (F). D. bifloris staining
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perturbation
Given that proliferation is diminished when GAGs are
perturbed and that FGF2 binding is affected by HS pertur-
bation, we also examined the localization of FGFR2,
another member of the FGF2 signaling complex. FGFR2
is found in collecting ducts and some nephron tubules in
appears in red. Apoptosis occurs primarily in stalks of the UB as described.Fig. 10. Localization of FGFR-2 in cultured isolated rat ureteric bud (UB). Isolated
control) or presence of chlorate 30 mM (B), heparitinase 100 mU/ml (C), or chothe developing kidney and is thought to be involved in the
induction of UB outgrowth and the mesenchymal–epithe-
lial conversion (Cancilla et al., 1999; Qiao et al., 2001).
Fig. 10 displays immunofluorescence of FGFR2 on the
isolated UB. Under control conditions (Fig. 10A), FGFR2
was found predominantly on the basolateral surfaces of the
epithelial cells that make up the UB, which is the surface
exposed to the extracellular matrix, and there appears to be
a predominance of expression at the tip of the UB branch.
When the isolated UB is cultured in media containing
various GAG-perturbing compounds, we found that FGFR2
localization was unchanged, at least at the level of immu-
nocytochemistry (Figs. 10B–D). This then suggests that
FGFR2 localization and expression is independent of GAG
function.
Next, we investigated if the change in morphology of
isolated UBs with altered GAGs was secondary to
changes in effector molecule localization or expression.
We first examined junctional proteins that delineate apical
and basal surfaces of the tubular epithelium, h-catenin, an
adherens junction protein, and occludin, a tight junction
protein. The spatial localization of these proteins appears
qualitatively unaffected by treatment with chlorate (Figs.
11D,E), heparitinase (Figs. 11G,H), or chondroitinase
(data not shown). We also found that the localization of
another key effector of branching morphogenesis, MT1-
MMP, a membrane-bound metalloproteinase involved in
matrix degradation of developing epithelial structures that
has been found to regulate UB branching morphogenesis
(Pohl et al., 2000a), was also unaffected by GAG
perturbation with chlorate or heparitinase as determined
by immunocytochemistry (Figs. 11F,I). As these mole-
cules are thought to be important in UB patterning, these
results seem to be generally consistent with a defect in
overall growth rather than patterning after non selective
HS perturbation.Discussion
The goal of the present study was to delineate the role of
heparan sulfate proteoglycans (HSPG) and chondroitin sul-UBs grown for 7 days in culture were stained for FGFR-2 in the absence (A,
ndroitinase ABC 100 mU/ml (D).
Fig. 11. Localization of effector molecules in cultured isolated rat ureteric bud (UB). Isolated UBs grown for 7 days in culture were stained for the adherens
junction protein, h-catenin (A, D, G), the tight junction protein, occludin (B, E, H), and the matrix metalloproteinase, MT1-MMP (C, F, I), in the absence (A, B,
C, control) or presence of chlorate 30 mM (D, E, F) or heparitinase 100 mU/ml (G, H, I). Occludin (B, E, H) is found on the apical surfaces of UB cells, the
outline of the UB is marked with the dashed line.
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phogenesis. The difference with previous, sometimes
conflicting studies, done in whole embryonic kidney about
a decade ago (Davies et al., 1995; Lelongt et al., 1988; Platt et
al., 1990) is that we have directly examined ureteric bud (UB)
branching in the recently developed isolated UB culture
system and placed these findings in the context of parallel
experiments done with the whole embryonic kidney in organ
culture. Furthermore, we have supplemented the studies with
microarray data in several pertinent in vitro model systems.
Branching morphogenesis in cell culture is known to be
greatly influenced by extracellular matrix composition
(Santos and Nigam, 1993). In this report, we show that
HSPGs play a prominent role in the process of UB branch-
ing morphogenesis while CSPGs appear less critically
involved. Some of our data are consistent with previously
published results that demonstrate that disruption of proteo-
glycans dramatically alters epithelial organogenesis of the
kidney (Davies et al., 1995; Platt et al., 1987). Our results
show that undersulfation of both HS and CS with chlorate
causes a reduction in the number of ureteric bud tips
presumably due to a primary effect of HS undersulfationsince specific degradation of CS chains with chondoitinase
ABC does not significantly affect UB branching. Using an
in vitro isolated UB culture assay, we found that the
branching abnormalities noted with HS perturbation occur
through a direct effect of HS upon the UB (rather than the
potential effects of HS perturbation on mesenchymal induc-
tion of UB branching). This mechanism may account for the
reduced number of UB branch tips seen in chlorate-treated
kidneys; in addition, HS may also have an effect upon
nascent MM-derived epithelial structures that ultimately
form nephrons and help determine nephron number. These
findings suggest that HS, presumably on the UB cell surface
or within the UB basement membrane, can modulate
branching morphogenesis in the developing kidney.
That perturbation of HS predominantly affects early UB
growth and branching in this study suggests that there may
be an HS ‘‘microenvironment’’ along the UB that modulates
specific growth factor signaling as well as the generation of
local and global gradients of stimulatory and inhibitory
growth factors (Nigam, 1995; Santos and Nigam, 1993;
Stuart et al., 1995). The generation of a local microenvi-
ronment of GAG chains relies upon the strictly controlled
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Because the synthesis of GAGs is not regulated at the
transcriptional level, spatiotemporal control must occur
through other mechanisms. Protein cores may play an
integral role in this regard. We found several protein core
genes that were developmentally regulated in both the UB
and MM including syndecan-1, syndecan-4, and versican.
Regulation of expression of other genes appeared to be
confined to the UB (glypican-1,2,3) or the MM (decorin)
alone, suggesting that there may also be microenvironments
within the MM that modulate developmental processes
during kidney organogenesis. The precise role of the core
proteins in development has not been well characterized,
although knockout data support their function in UB
branching morphogenesis. This is demonstrated in glypi-
can-3-deficient mice that display a phenotype very similar to
the human Simpson–Golabi–Behmel syndrome, character-
ized by renal cystic dysplasia (Pilia et al., 1996). In the
human Simpson–Golabi–Behmel syndrome, affected indi-
viduals have a mutation in the glypican-3 gene.
Although the proteoglycan core proteins determine the
spatial and temporal location of the HS chains, the HS
biosynthetic enzymes ultimately determine HS fine struc-
ture. Environments of specifically sulfated HS chains may
represent a subset of the overall HS microenvironment that
eventually governs the growth-factor-mediated morphoge-
netic event. One fundamental mechanism by which HS
facilitates growth factor signaling is to stabilize the growth
factor and receptor complex to sustain signaling (reviewed
in Ornitz, 2000). HS can also act as a coreceptor for growth
factor signaling (reviewed in Tumova et al., 2000). These
types of HS growth factor interactions have been well
studied in FGF2 signaling (Pye et al., 1998; Rapraeger et
al., 1991; Yayon et al., 1991). In UB branching morpho-
genesis, HS–growth factor–growth factor receptor com-
plexes and their downstream signals likely determine the
morphogenetic event that occurs in the developing epithelial
structure (Nigam, 2003). We have previously reported that
various stimulatory and inhibitory growth factors are able to
‘‘sculpt’’ the UB during morphogenesis (Bush et al., 2004;
Qiao et al., 2001). In the setting of HS perturbation, one
might expect that the binding or activity of fibroblast growth
factors other than FGF2 is similarly disrupted so that the
normal instructive signals that govern the patterning and
growth of the kidney are interrupted.
Another function of HSPGs may be to create a ‘‘sink’’ of
growth factors or other signaling molecules that can be
released in a time- and gradient-dependent fashion. The
substantial decrease in labeled FGF2 binding seen whole
embryonic kidney and isolated UB after treatment with
chlorate supports this notion. Furthermore, the release of
FGF2 from the basement membrane HSPG, perlecan occurs
via matrix metalloproteinases that degrade the protein com-
ponent of the proteoglycan (Whitelock et al., 1996). HS also
bindsMMPs andmay provide a reservoir ofMMPswithin the
extracellular space (Yu and Woessner, 2000). Matrix metal-loproteinases have been shown to be modulators of UB
branching morphogenesis in vitro (Pohl et al., 2000a), and
their activity is attenuated by heparin and heparan sulfate (Yu
and Woessner, 2000). In this study, the localization of MT1-
MMP in the branching UB was not qualitatively altered by
GAG perturbation although its activity, which was not
measured in this study, may be changed in this setting.
It is becoming evident that HS fine sulfation pattern plays
a significant role in many of the growth factor mediated
morphogenetic events that are required for branching mor-
phogenesis, from modulation of growth factor signaling to
gradient formation (Nigam, 1995; Santos and Nigam, 1993;
Stuart et al., 1995). There is now data to suggest that 2-O-
and 6-O-sulfated HS are involved in different aspects of
growth factor signaling (reviewed in Faham et al., 1998;
Lyon and Gallagher, 1998). Cell culture models have shown
that chlorate treatment of Madin–Darby canine kidney cells
results in differential effects upon 6-O-sulfation vs. 2-O-
sulfation (Safaiyan et al., 1999). In this model, low chlorate
concentrations (5–20 mM chlorate) selectively reduced the
6-O-sulfation of HS, whereas treatment with higher con-
centrations of chlorate (50 mM) reduced both 2-O- and 6-O-
sulfation. In our experiments with high concentrations of
chlorate, we may be inhibiting both 6-O-sulfation and 2-O-
sulfation, and thus approximating a milieu that is similar to
the 2-O-sulfotransferase knockout in which there is failure
of ureteric bud branching. Heparan sulfate has been reported
to be required for GDNF signaling (Barnett et al., 2002),
and a recent study has shown that the bioactivity of GDNF
may be dependent on binding to 2-O-sulfate-rich, heparin-
related glycosaminoglycans (Rickard et al., 2003). Interest-
ingly, GDNF knockout mice also have renal agenesis
(Sanchez et al., 1996); thus the phenotype we observe with
high dose chlorate may, in part, be due to impairment of
GDNF signaling that is mediated by 2-O-sulfated HS.
Kidneys treated with lower concentrations of chlorate,
which may be selectively affecting 6-O-sulfation, have
reduced branch tip numbers without appreciable differences
in branching pattern. These findings could have clinical
relevance as it may be that alterations in nephron number,
which are postulated to lead to the development of hyper-
tension (Brenner et al., 1988), and may in some cases be due
to a proteoglycan-related aberration (Shah et al., 2004).
Taken together, our findings begin to bring together the
interaction between growth factors, growth factor receptors,
and proteoglycans in the patterning and growth of the
embryonic kidney. While others have suggested that both
HSPGs and CSPGs are necessary for ureteric bud branch-
ing, we find that isolated UB branching is predominantly
modulated by HSPGs. However, it is plausible that CSPGs
also modulate branching but on a more subtle level; through
more detailed morphometric quantification and gene expres-
sion analysis, the role of CSPGs on branching morphogen-
esis may become apparent.
Branching of the UB is an iterative process of branch
point formation and stalk elongation that results in an
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which UB branching proceeds through stages that are
broadly characterized by (1) UB outgrowth from the Wolf-
fian duct (prebranching); (2) a rapid branching and growth
phase where ‘‘feedforward’’ mechanisms predominate; (3) a
slowing down of branching regulated by feedback mecha-
nisms; and (4) a stop branching/maturation process (Bush et
al., 2004; Nigam, 2003). These stages can be distinguished
by a unique combination/set of heparin-binding growth
factors; for example, FGFs and pleiotrophin modulate rapid
growth and branching (stage 1) (Qiao et al., 2001; Sakurai et
al., 2001), while members of the TGFh superfamily act to
slow branching (stage 2) (Bush et al., 2004). Disruption of
phase-specific molecular pathways may result in groups of
syndromes that are phenotypically similar (Shah et al.,
2004). For example, renal agenesis occurs when initial
growth and branching signals are interrupted and cystic
kidney disease tends to occur in the setting of improper stop
signals. Based on this and other recent studies, we propose
that these stages are pivotally regulated (both positively and
negatively) by growth factor–sulfated proteoglycan interac-Fig. 12. Proposed model for the role of heparan sulfate proteoglycans in ureteri
[various core protein isoforms and variable length and sulfation of the heparan sulf
signal, including the creation of growth factor gradients. For example, in this cartoo
unique core protein–variably sulfated HS combinations) results in branch point fo
to stalk elongation. Heparan sulfate proteoglycans (HSPG) interact with man
inhibiting) factors (see text for details). HSPGs may mediate the transition from
branching ceases through the differential binding of stimulatory and inhibitory gro
branching. For example, near the tips of the UB, HSPGs may modulate growth
However, at the stalks of the UB, HSPGs may modulate inhibitory signals to prev
through a change in core protein expression (e.g., syndecan to glypican) or through
N-sulfation). Different HS chains on the same protein core may be able to modula
level. Not shown are postulated growth factor gradients that may be HS dependetions (Bush et al., 2004; Nigam, 2003; Stuart et al., 2003). In
addition, although not discussed here, these morphogenetic
stages may also be influenced by HSPG interactions with
insoluble ECM ligands. Studies of syndecan-4-deficient
fibroblasts show that these cells have a reduced rate of
migration during in vitro wound healing perhaps due to
altered fibronectin signaling of actin stress fiber assembly
and focal adhesion (Echtermeyer et al., 2001). Similar
mechanisms may be operative during invasion of the UB
into the MM. This interplay among soluble and insoluble
ligands bound by sulfated proteoglycans, matrix proteases
capable of liberating bound ligands, and receptor tyrosine
kinases, which depend on interactions with both their ligands
and proteoglycans for activation, presumably set in motion
the intracellular events that lead to the developmental pro-
cesses involved in branching morphogenesis.
Based on our findings, we propose a model (Fig. 12)
where microenvironments of HS, established through spa-
tiotemporally controlled expression of protein cores and
biosynthetic enzymes, modulate a variety of morphogenetic
events from branch point formation to stalk elongation.c bud (UB) branching morphogenesis. The molecular diversity of HSPGs
ate (HS) chain] may allow for spatiotemporal modulation of the morphogen
n, the binding of growth factor-a (GF-a) to a unique HSPG (colors represent
rmation while the binding of growth factor-b (GF-b) to another HSPG leads
y stimulatory (growth/branch-promoting) and inhibitory (growth/branch-
a stage characterized by active growth and branching to a stage in which
wth factors (GF), effectively creating a ‘‘switch’’ between different stages of
and branch promoting signals to propel the branching epithelium forward.
ent further budding and maintain tubule caliber. This transition may occur
a change in HS sulfation pattern (predominant 6-O-sulfation to predominant
te these signals allowing for fine-tuning of these signals even at the cellular
nt.
D.L. Steer et al. / Developmental Biology 272 (2004) 310–327 325These events likely occur through creation of growth factor
gradients and regulation of growth factor–receptor binding,
the specificity of which is dictated by the HS moieties. These
microenvironments are likely dynamic and are modified
based on the growth factor milieu and stage of development.
As a result, the expression of protein cores with variably
sulfated GAGs may, along with stage-specific heparin-bind-
ing growth factors, act as a switch to transition the develop-
ing collecting system from one stage of branching
morphogenesis (e.g., rapid UB growth and branching) to
another (e.g., slowing down of branching) through the
regulated signaling of branch promoting and branch inhib-
itory factors. Although this is a simplified view of an
extremely complex system, one can begin to envision how
HSPGs are central to UB branching morphogenesis and how
PG-mediated control of a developmental process provides
the ‘‘fine tuning’’ necessary to instruct the complex inter-
actions that result in the development of a specific organ.Acknowledgments
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